Synthekine is a clinical-stage biotechnology company discovering, developing, and commercializing the next generation of selective cytokine therapeutics. The company believes cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm for cancer and inflammatory disease. - View it on GitHub